Bone Index Ltd. (Bindex) has developed the Bindex® device, which is a reliable and accurate tool for diagnosing osteoporosis. This technology is designed to provide results that are comparable to DXA (Dual-energy X-ray Absorptiometry), a standard method for measuring bone density. The Bindex® device is noted for its speed, delivering results in just 30 seconds, which facilitates a higher volume of assessments and allows for immediate initiation of treatment and medication when necessary. This efficiency is crucial in clinical settings where timely decision-making is essential for patient care.

In addition to its accuracy and rapid results, the Bindex® device is designed for ease of use in various environments. Its user-friendly interface allows healthcare professionals to conduct assessments conveniently at the patient's location, enhancing accessibility to osteoporosis diagnostics. This portability and simplicity make the Bindex® a valuable tool in both clinical and non-clinical settings, ensuring that patients receive timely and effective care for osteoporosis management.

Finland

Bone Index Ltd. is a medical device company with the game-changer point-of-care technology (Bindex®) in osteoporosis screening/diagnostics. The overall aim is to prevent osteoporotic fractures, improve surgical outcomes, and improve the quality of life for families in the United States.

Bone Index Ltd. (Bindex)

Company Details